Throughout the past decade, there has been a rapid growth in the development of
protein/peptide-based therapeutics. These therapeutics have found widespread applications …

Microfluidics is an emerging technology that can be employed as a powerful tool for
designing lipid nano-microsized structures for biological applications. Those lipid structures …

Particle-based drug delivery systems have a demonstrated value in osteoarthritis treatment.
Research in this area trends to developing functional particles to improve the therapeutic …

In recent years, several studies have shown that the use of solid lipid nanoparticles (SLN) as
a colloidal drug delivery system was more advantageous than lipid emulsions, liposomes …

In recent years, peptide/protein drugs have attracted considerable attention owing to their
superior targeting and therapeutic effect and fewer side effects compared with chemical …

Diabetes is a chronic metabolic disease characterized by lack of insulin in the body leading
to failure of blood glucose regulation. Diabetes patients usually need frequent insulin …

Solid lipid nanoparticles (SLNs) can combine the advantages of different colloidal carriers
and prevent some of their disadvantages. The production of nanoparticles by means of …

Despite tremendous efforts, the world continues its fight against the common chronic
disease-diabetes. Diabetes is caused by elevated glucose levels in the blood, which can …

Oral drug administration has an important role in medical treatment. Attempts to develop
drug microcarriers with desired features for extended duration and improved absorption is …

Oral delivery is considered the favoured route of administration for both local and systemic
delivery of active molecules. Formulation of drugs in conventional systems and …